<DOC>
	<DOC>NCT02881216</DOC>
	<brief_summary>This study sought to compare procedural performance of a new coronary stent generation, that is already available in Germany, with hitherto established current drug-eluting stents.</brief_summary>
	<brief_title>Procedural Advantages of a Novel Drug-Eluting Coronary Stent</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Imidacloprid</mesh_term>
	<criteria>CAD for PCI, consecutive patients Age under 18 Bare Metal Stents or Scaffolds</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>